Childhood adversity may trigger obesity in adolescence

Adicet Bio is shelv­ing plans to use its lead as­set to treat can­cer and in­stead shift­ing its tar­get to au­toim­mune dis­eases. The move, dis­closed by

Late last week, the FDA ap­proved an sBLA for un­brand­ed la­bel­ing for Ab­b­Vie’s megablock­buster Hu­mi­ra (adal­i­mum­ab), open­ing the door for a po­ten­tial new way to